OBJECTIVE: To explore the efficacy and feasibility of @entity235 days moxibustion plaster therapy in treatment of @entity2023 of different patterns/syndromes. METHODS: @entity2023 of @entity358 and invasion of cold, @entity4559 and @entity8 , 56 @entity1 for each pattern/syndrome were randomized into a plaster therapy group and a nasal spray group, 28 cases in each one. In the plaster therapy group, according to the pattern/syndrome differentiation, with literature retrieval method, 3 acupoints of high frequency utility in clinic were selected as one group in acupoint plaster therapy. For @entity358 and invasion of cold pattern/syndrome, Feishu (BL 13), Fengmen (BL 12) and Hegu ( @entity9154 ) were selected. For @entity4559 pattern/syndrome, Pishu (BL 21), Zusanli (ST 36) and Dazhui (GV 14) were selected. For @entity8 pattern/ syndrome, Shenshu (BL 23), Dingchuan (EX-B 1) and Bailao (EX-HN 15) were selected. Separately, on July 13, 2013, July 23, 2013, August 2, 2013 and August 12, 2013, the aucpoint plaster therapy was applied, 2 to 4 h (1 to 2 h for @entity1 ) each time. In the nasal spray group, @entity39521 aqueous nasal spray, 2 presses one nostril each time, 2 to 3 times a day, continuously for 4 weeks. The symptom score and efficacy were compared before and after treatment in the @entity1 of the two groups. RESULTS: The symptom scores of 3 patterns/syndromes were all apparently improved after treatment as compared with those before treatment in the @entity1 of the two groups (all P<0.05), and the result in the plaster therapy group was better than that of the nasal spray group (P<0.05, P<0.01). For @entity358 and invasion of cold pattern/syndrome, the total effective rate was 87.3% (20/24) in the plaster therapy group, better than 84.6% (22/26) in the nasal spray group (P<0.05). For @entity4559 pattern/syndrome, the total effective rate was 83.3% (20/24) in the plaster therapy group, obviously better than 76.9% (22/26) in the nasal spray group (P<0.05). For @entity8 pattern/syndrome, the total effective rate was 79.2% (19/24) in the plaster therapy group, better than 76.9% (22/26) in the nasal spray group (P<0.05). CONCLUSION: The @entity235 days moxibustion plaster therapy achieves definite efficacy on @entity2023 at the acupoints selected based on the differentiation of different patterns/syndromes and the efficacy is better than @entity39521 aqueous nasal spray.

[Clinical observation of @entity235 days moxibustion plaster therapy in treatment of XXXX of different patterns/syndromes].

@entity1 :: ('9606', 'Species') :: ['children', 'patients'] @entity4559 :: ('MESH:D013160', 'Disease') :: ['spleen qi deficiency'] @entity8 :: ('MESH:D007674', 'Disease') :: ['kidney yang deficiency'] @entity9154 :: ('643418', 'Gene') :: ['LI 4'] @entity2023 :: ('MESH:D006255', 'Disease') :: ['Allergic rhinitis', 'allergic rhinitis'] @entity235 :: ('9615', 'Species') :: ['dog'] @entity358 :: ('MESH:D008171', 'Disease') :: ['lung deficiency'] @entity39521 :: ('CHEBI:3002', 'Chemical') :: ['beclometasone dipropionate']
@entity2023 :: (MESH:D006255,Disease) :: ['allergic rhinitis']
